Clinical Trial Update: Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation

View source ↗

Summary

A completed clinical trial validating a Quality of Life questionnaire for patients who had changes in tacrolimus dosing after kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Kidney Transplantation | Status: COMPLETED